Stockholm - Delayed Quote SEK

Elekta AB (publ) (EKTA-B.ST)

74.45 -0.55 (-0.73%)
At close: 5:29 PM GMT+2

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
NameTitlePayExercisedYear Born
Dr. Laurent Leksell Founder & Chairman 1.64M -- 1952
Mr. Gustaf Salford President & CEO 14.62M -- 1977
Mr. Tobias Hagglov Chief Financial Officer -- -- 1978
Mr. Peter Nyquist Head of Investor Relations -- -- 1965
Mr. Jonas Bolander Executive VP of Group Functions, Secretary & General Counsel -- -- 1966
Mr. Mattias Thorsson VP and Head of Corporate Communications & Public Affairs -- -- --
Ms. Anna Conneryd Lundgren Executive VP & Chief People Officer -- -- 1985
Mr. John Lapré President of Brachy & Neuro Solutions -- -- 1964
Mr. Maurits Wolleswinkel President of Linac & Software Solutions -- -- 1971
Mr. Habib Nehme Chief Commercial Officer -- -- 1964

Elekta AB (publ)

Kungstensgatan 18
Box 7593
Stockholm, 103 93
Sweden
46 8 58 72 54 00 https://elekta.com
Sector: 
Healthcare
Full Time Employees: 
4,584

Description

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Corporate Governance

Elekta AB (publ)’s ISS Governance QualityScore as of April 1, 2024 is 5. The pillar scores are Audit: 4; Board: 7; Shareholder Rights: 8; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Feb 26, 2024
    Ex-Dividend Date

Upcoming Events

Jun 05, 2024
Elekta AB (publ) Earnings Call

Related Tickers